Respiratory complications of lung cancer treatment;Complications respiratoires du traitement du cancer bronchique

Medecine et Hygiene

Volumn 58, Issue 2295, 2000, Pages 783-785

  Bréchot, Jeanne Marie ^a  

^a Service de Pneumologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; MITOMYCIN; NAVELBINE; PACLITAXEL; TIRAPAZAMINE; VINCA ALKALOID; VINCRISTINE; VINDESINE;

HUMAN; INTERSTITIAL PNEUMONIA; LUNG CANCER; LUNG EMBOLISM; LUNG FUNCTION; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; REVIEW;

EID: 0342699759     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Deslauriers J, Ginsberg RJ, Piantadosi S, Fournier B. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest 1994 ; 106 (Suppl. 6) : 329S-30S.
2. Mitsudomi T, Mizoue T, Yoshimatsu T, et al. Postoperative complications after pneumonectomy for treatment of lung cancer; Multivariate analysis. J Surg Oncol 1996 ; 61 : 218-22.
3. Yano T, Yokoyama H, Fukuyuma Y, Takai E, Mizutani K, Ichinose Y. The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardiothorac Surg 1997 ; 11 : 445-9.
4. (white star) Licker M, de Perrot M, Höhn L, et al. Perioperative mortality and major cardiopubnonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg 1999 ; 15: 314-9.
5. Ill MR, Gandara DR, Yuo H-S, Swift PS, Kroll S, Shrieve DC, et al. Radiation pneumonitis following combined modality therapy for lung cancer : Analysis of prognostic factors. J Clin Oncol 1995 ; 13 : 2606-12.
6. (white star) PORT Meta-analysis Tialists Group. Postoperative radiotherapy in nonsmall cell lung cancer : Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998 ; 352 : 257-63.
7. Dautzenberg B, Arriagada R, Boyer Chammard A, et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer 1999 ; 86 : 265-73.
8. Lebeau B, Urban T, Bréchot JM, et al. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. Cancer 1999 ; 86 : 1480-7.
9. (white star) Quoix E, Mornex F, Milleron B, Pauli G. Manifestations respiratoires radio-et chimio-induites. Rev Mal Respir 1997 ; 14 : 341-53.
10. Shepherd FA. Chemotherapy for nonsmall cell lung cancer : Have we reached a new plateau? Semin Oncol 1999 ; 26 (Suppl. 4) : 3-11.
11. Ghaemmaghani M, Jett JR. New agents in the treatment of small cell lung cancer. Chest 1998 ; 13 : 86S-91S.
12. McCarthy JT, Staats BA. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome. Chest 1986 ; 89 : 608-11.
13. Rouzatul Ph, Estivals M, Pujazon MC, Carles P, Lauque D. Complications respiratoires de l'association vinarelbine-mitomycine. Rev Mal Respir 1999 ; 16 : 81-4.
14. Baker WJ, Fistel SJ, Jones R, Weiss RB. Interstitial pneumonitis associated with ifosfamide therapy. Cancer 1990 ; 65 : 2217-21.
15. Pavlakis N, Bell DR, Millward MJ, Levi JA. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 1997 ; 80 : 286-91.